Ignite Creation Date:
2024-05-05 @ 10:13 PM
Last Modification Date:
2024-10-26 @ 10:15 AM
Study NCT ID:
NCT01059500
Status:
COMPLETED
Last Update Posted:
2023-03-23
First Post:
2010-01-28
Brief Title:
Assessment of Acute Disease to Reduce Imaging Costs
Sponsor:
Wake Forest University Health Sciences
Organization:
Wake Forest University Health Sciences
Study Overview
Official Title:
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
QUAADRICs
Brief Summary:
Overtesting for Acute Coronary SyndromeACS and Pulmonary Embolism PE in low risk Emergency DepartmentED patients can increase exposure of nondiseased patients to radiation intravenous contrast and anticoagulation This project addresses question of whether quantitative Pre-Test ProbabilityPTP assessed from two validated web-based computer algorithms the project webtool can improve the diagnostic evaluation of adult patients with charted evidence of chest pain and dyspnea After a validation phase the main study will randomize patients to either the Standard care group or the Intervention group which will receive the output of the ACS and PE webtool that includes the PTP estimates of ACS and PE and one of three recommendations regarding next steps 1 No further testing 2 Exclusion with a biomarker protocol or 3 Immediate imaging - empiric anticoagulation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None